Operating margin moved 232 bp lower
Operating margin changed -232 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
35.48%→33.16%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →GEN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income increased 59.3%
Net income changed +59.3% from the comparable as-filed period.
$135.0M→$215.0M2 prior comparisons
Gross margin moved 174 bp lower
Gross margin changed -174 basis points from the comparable as-filed period.
78.76%→77.02%2 prior comparisons
Current long-term debt decreased 37.2%
Current long-term debt changed -37.2% from the comparable as-filed period.
$288.0M→$181.0M3 prior comparisons
Debt / revenue moved 9461 bp lower
Debt / revenue changed -9461 basis points from the comparable as-filed period.
705.09%→610.48%2 prior comparisons
Operating cash flow / net income decreased 33.4%
Operating cash flow / net income changed -33.4% from the comparable as-filed period.
3.03→2.022 prior comparisons
Receivables / revenue moved 331 bp higher
Receivables / revenue changed +331 basis points from the comparable as-filed period.
24.98%→28.29%2 prior comparisons
Debt / equity moved 6768 bp lower
Debt / equity changed -6768 basis points from the comparable as-filed period.
374.76%→307.08%2 prior comparisons
Revenue increased 6.3%
Revenue changed +6.3% from the comparable as-filed period.
$1.3B→$1.3B2 prior comparisons
Trade receivables increased 20.4%
Trade receivables changed +20.4% from the comparable as-filed period.
$314.0M→$378.0M3 prior comparisons
Free-cash-flow proxy increased 6.2%
Free-cash-flow proxy changed +6.2% from the comparable as-filed period.
$405.0M→$430.0M2 prior comparisons
Stockholders' equity increased 12.3%
Stockholders' equity changed +12.3% from the comparable as-filed period.
$2.4B→$2.7B2 prior comparisons
Operating cash flow increased 6.1%
Operating cash flow changed +6.1% from the comparable as-filed period.
$409.0M→$434.0M2 prior comparisons
Debt / assets moved 204 bp lower
Debt / assets changed -204 basis points from the comparable as-filed period.
54.17%→52.14%3 prior comparisons
Operating income decreased 0.7%
Operating income changed -0.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$446.0M→$443.0M2 prior comparisons
Reported total debt decreased 8.0%
Reported total debt changed -8.0% from the comparable as-filed period.
$8.9B→$8.2B3 prior comparisons
Gross debt decreased 8.0%
Gross debt changed -8.0% from the comparable as-filed period.
$8.9B→$8.2B3 prior comparisons
Current assets decreased 11.2%
Current assets changed -11.2% from the comparable as-filed period.
$1.4B→$1.3B3 prior comparisons
Shares outstanding decreased 2.8%
Shares outstanding changed -2.8% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
615,869,113→598,587,0328 prior comparisons
SBC / revenue moved 121 bp lower
SBC / revenue changed -121 basis points from the comparable as-filed period.
5.25%→4.04%2 prior comparisons
Current liabilities decreased 4.8%
Current liabilities changed -4.8% from the comparable as-filed period.
$2.9B→$2.7B3 prior comparisons
Noncurrent long-term debt decreased 7.0%
Noncurrent long-term debt changed -7.0% from the comparable as-filed period.
$8.6B→$8.0B3 prior comparisons
Stock-based compensation decreased 18.2%
Stock-based compensation changed -18.2% from the comparable as-filed period.
$66.0M→$54.0M2 prior comparisons
Research & development increased 8.3%
Research & development changed +8.3% from the comparable as-filed period.
$109.0M→$118.0M2 prior comparisons
Total assets decreased 4.4%
Total assets changed -4.4% from the comparable as-filed period.
$16.4B→$15.6B3 prior comparisons
Gross profit increased 3.9%
Gross profit changed +3.9% from the comparable as-filed period.
$990.0M→$1.0B2 prior comparisons
Working capital decreased 1.7%
Working capital changed -1.7% from the comparable as-filed period.
-$1.4B→-$1.5B3 prior comparisons
Capex / revenue moved 2 bp lower
Capex / revenue changed -2 basis points from the comparable as-filed period.
0.32%→0.30%2 prior comparisons
Working capital / assets moved 55 bp lower
Working capital / assets changed -55 basis points from the comparable as-filed period.
-8.74%→-9.29%3 prior comparisons
R&D / revenue moved 16 bp higher
R&D / revenue changed +16 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
8.67%→8.83%2 prior comparisons
Current ratio decreased 6.8%
Current ratio changed -6.8% from the comparable as-filed period.
0.5→0.473 prior comparisons
Operating cash-flow margin moved 5 bp lower
Operating cash-flow margin changed -5 basis points from the comparable as-filed period.
32.54%→32.49%2 prior comparisons
Free-cash-flow margin moved 3 bp lower
Free-cash-flow margin changed -3 basis points from the comparable as-filed period.
32.22%→32.19%2 prior comparisons
Capital expenditure unchangedd 0.0%
Capital expenditure changed +0.0% from the comparable as-filed period.
$4.0M→$4.0M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.